DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Stem Cells/WntStem Cells/Wnt
  5. /SmoSmo
  6. /Bms-833923Bms-833923
Chemical structure of CAS 1059734-66-5

Bms-833923

CAS No.1059734-66-5
MDL No.MFCD25976660
MFC30H27N5O
MW473.60
InChI KeyKLRRGBHZCJLIEL-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1059734-66-5
Product NameBms-833923

Biological Targets

SMO

Associated Conditions

small cell lung carcinoma·esophageal carcinoma·stomach neoplasm·nevoid basal cell carcinoma syndrome·leukemia·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor.

Bioinformation • Vol. 10, Issue 12 • 2014
PMID: 25670876PMC: PMC4312366DOI: 10.6026/97320630010737

The dawn of hedgehog inhibitors: Vismodegib.

Journal of pharmacology & pharmacotherapeutics • Vol. 4, Issue 1 • 2013
PMID: 23662017PMC: PMC3643342DOI: 10.4103/0976-500X.107628

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact